News

20 March, 2019

Tetraneuron, resident company of Johnson & Johnson Innovation – JLABS

Tetraneuron, resident company of Johnson & Johnson Innovation – JLABS Tetraneuron, a spin-off of Jose M. Frade’s lab at the Cajal Institute, is a resident company […]
30 November, 2018

XVII EDITION – Farma-Biotech Program

Participation in the XVII edition of the Farma-Biotech Program Different Spanish biotechnology companies and research groups, including Tetraneuron, presented on Wednesday, November, 28, 2018, a total […]
10 October, 2018

European patent for our Therapy

Therapy: Publication of the European patent grant. On September 5, 2018, the European Patent Office granted the patent for our therapy with No. EP2783696 “Phosphorylation on the Thr-248 […]
28 September, 2018

BIOSPAIN 2018

Presenting company in BIOSPAIN 2018 Tetraneuron was selected to make a company presentation during the BIOSPAIN Congress that took place in Seville in September 25-27, 2018   […]
17 October, 2017

Spanish patent for our Biomarker

Biomarker: Publication of the Spanish patent grant. On October 9, 2017, the Spanish Patent and Trademark Office granted the patent for our biomarker with No. ES2598885 ” Method […]
29 September, 2017

Tetraneuron in ASEBIO Investor Day

Tetraneuron in ASEBIO Investor Day 2017 Tetraneuron was one of the 30 Spanish biotech start-ups selected to present their project at ASEBIO Investor Day, on September 26-27, […]
20 July, 2017

Tetraneuron presents its Poster at AAIC17

Tetraneuron presents its Poster at AAIC17 Last Monday, July 17th José María Frade, Tetraneuron’s Scientific Director, presented at AAIC17 his Poster: “A Mutant Form of E2F4 […]
25 May, 2017

Japanese patent for our Therapy

Therapy: Publication of the Japan patent grant. On March 22, 2017, the Japanese Patent Office granted the patent for our therapy with No. 6100276 “Phosphorylation on the Thr-248 […]
12 May, 2017

New scientific publication of Tetraneuron

Neuronal tetraploidization in the cerebral cortex correlates with reduced cognition in mice and precedes and recapitulates Alzheimer’s-associated neuropathology The study has recently been accepted and published […]
13 March, 2017

US patent for our Therapy

Therapy: Publication of the US patent grant. On February 14, 2017, the United States Patent and Trademark Office granted the patent for our therapy with No. 9,567,384 […]

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR